Skip to main content
. 2015 Mar 16;36(5):585–597. doi: 10.1093/carcin/bgv021

Figure 5.

Figure 5.

Effect of Snail2 constitutive deletion in hematopoietic progenitors during skin chemical carcinogenesis. (A) Tumor burden (lesions/mouse) showing the differences between Snail2 +/+_BMSnail2 −/− and Snail2 +/+_BMSnail2 +/+ mice after DMBA/TPA treatment; n = 7 mice per experimental group. *P ≤ 0.05. (B) Tumor size comparison between Snail2 +/+_BMSnail2 +/+ and Snail2 +/+_BMSnail2 −/− lesions. (C) Flow cytometry analysis of CD11b+/Gr-1+ population in blood, BM and tumors in Snail2 +/+_BMSnail2 +/+ and Snail2 +/+_BMSnail2 −/− mice after DMBA/TPA treatment. (D) Flow cytometry analysis of CD4+, CD8+, CD19+ and F4/80+ cell populations of Snail2 +/+_BMSnail2 +/+ and Snail2 +/+_BMSnail2 −/− tumors. (C) and (D) n = 4 and 5 for Snail2 +/+_BMSnail2 +/+ and Snail2 +/+_BMSnail2 −/− mice, respectively. t-Test, *P ≤ 0.05, **0.001 < P < 0.005, ***P ≤ 0.001.